Injective's institutional services arm has been registered as a transfer agent with the U.S. Securities and Exchange Commission. The affiliated entity can now maintain securities ownership records, a core function in the traditional financial system. The registration adds a piece of regulated market infrastructure to Injective's push into tokenized assets.
What the registration covers
Transfer agents keep the official record of who owns a security. They track transactions, cancel old certificates, and issue new ones. Injective's institutional arm now holds that role under SEC oversight. That means it can handle the bookkeeping for securities issued on blockchain rails, bridging the gap between crypto-native settlement and regulated record-keeping.
The registration is not a license to trade or underwrite. It's a narrower, back-office function. But it's a necessary one for any issuer that wants to operate within U.S. securities law. Without a registered transfer agent, a tokenized security can't legally exist in the traditional sense.
Injective has been building infrastructure for tokenized real-world assets, from funds to debt instruments. The problem has always been compliance. A token might trade on a decentralized exchange, but the ownership records still need to live somewhere regulators can see them. That's where the transfer agent role comes in.
Now Injective's own institutional arm can serve that function. It gives the company a way to offer a full stack: issuance, trading, and now the regulated record-keeping layer. For institutional clients, that's a big deal. They don't want to rely on a patchwork of unregulated intermediaries.
The regulatory step
The SEC registration is a formal acknowledgment that Injective's institutional arm meets the standards to act as a transfer agent. It's not a blanket approval of everything Injective does. But it's a concrete sign that the company is willing to operate inside the rules, not around them.
The move comes as tokenized assets keep drawing attention from traditional finance. Having a registered transfer agent in-house could make Injective a more attractive partner for issuers who want to tokenize without leaving the regulated system. The registration is now in effect, and the company can start offering the service immediately.
